Yingqi Hua

7.4k citations
104 papers · 3.7k indexed · 1 hit paper · h-index 33
Topics
Sarcoma Diagnosis and Treatment (14 papers)Cancer-related molecular mechanisms research (11 papers)Cancer, Hypoxia, and Metabolism (9 papers)

In The Last Decade

Yingqi Hua

96 papers receiving 3.7k citations

Hit Papers

Immunogenic cell death in cancer therapy: Present and eme...20192026202120232019100200300400500

Peers

Yingqi Hua
Comparison fields: 5 of 127
  • Molecular Biology 1.8k
  • Oncology 827
  • Cancer Research 776
  • Pulmonary and Respiratory Medicine 654
  • Biomedical Engineering 589
Replace Zhengdong Cai with:
Zhengdong Cai China
Ke Xu China
Wantao Chen China
Chunhong Yan United States
Chang Zou China
Sofia Avnet Italy
Jin Cheng China
Jingxuan Pan China
Hesham M. Amin United States
Martin R. Berger Germany
Yingqi Hua relative to Zhengdong Cai China Zhengdong Cai's profile →
Citations per field
00.5×4.3×
Zhengdong Cai · 1×
Citations per year

Countries citing papers authored by Yingqi Hua

Since Specialization
Citations

This map shows the geographic impact of Yingqi Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqi Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqi Hua more than expected).

Fields of papers citing papers by Yingqi Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingqi Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqi Hua. The network helps show where Yingqi Hua may publish in the future.

Co-authorship network of co-authors of Yingqi Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Yingqi Hua. A scholar is included among the top collaborators of Yingqi Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqi Hua. Yingqi Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 9
6 30
7 23
8 22
9 63
10 100
11 12
12 13
13 11
14 27
15 27
16 19
17 28
18 18
19 26
20 28

About Yingqi Hua

Yingqi Hua is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 104 papers that have together received 3.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (776 citations), Toxicology (118 citations) and Oncology (827 citations). Yingqi Hua has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhengdong Cai, Gangyang Wang, Dongqing Zuo, Fei Yin, Jingyi Zhou, Zhuoying Wang, Hongxia Wang, Mengxiong Sun, Hongsheng Wang and Wei Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026